Overview

Fludrocortisone in Healthy Volunteers (AFLUCO4)

Status:
Completed
Trial end date:
2016-04-20
Target enrollment:
Participant gender:
Summary
Fludrocortisone, in association with hydrocortisone, has demonstrated an improvement in survival in septic shock patients with relative adrenal insufficiency. However, the utility of low doses of steroids and in particular of mineralocorticoids in septic shock is still discussed. The purpose of the investigators study is to investigate the effects of 3 increasing doses of fludrocortisone (100 μg, 200 μg, 400 μg) in order to determine which dose allows the best pressor response to phenylephrine in healthy volunteers, and simultaneously assess their respective hemodynamic and biological effects.
Phase:
Phase 2
Details
Lead Sponsor:
Rennes University Hospital
Treatments:
Fludrocortisone